Novo valuation surpasses Tesla on experimental obesity drug data

Go back to Novo valuation surpasses Tesla on experimental obesity drug data
Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1169.60 -19.12 (1.61%)
Previous Close $1188.72    52 Week High $88.16 
Open $1183.50    52 Week Low $67.88 
Day High $1186.09    P/E 270.74 
Day Low $1131.21    EPS $4.32 
Volume 3,093,341       

NOVO-NORDISK A/S (NYSE: NVO) Delayed: 38.18 -0.08 (0.21%)
Previous Close $38.26    52 Week High $59.00 
Open $37.80    52 Week Low $32.80 
Day High $38.23    P/E N/A 
Day Low $37.51    EPS $0.00 
Volume 11,816,516       

ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) Delayed: 27.73 -0.81 (2.84%)
Previous Close $28.54    52 Week High $5.17 
Open $28.37    52 Week Low $0.94 
Day High $28.49    P/E N/A 
Day Low $27.05    EPS $0.00 
Volume 8,693,107